Bradmer Pharmaceuticals Inc. (TSE:GLX) Given Average Rating of “Buy” by Brokerages

Shares of Bradmer Pharmaceuticals Inc. (TSE:GLX) have been assigned a consensus rating of “Buy” from the six analysts that are currently covering the stock, MarketBeat reports. Two research analysts have rated the stock with a hold rating, one has given a buy rating and three have issued a strong buy rating on the company.

A number of research analysts have recently issued reports on GLX shares. Citigroup raised Bradmer Pharmaceuticals to a “hold” rating in a report on Tuesday, February 24th. ATB Cormark Capital Markets downgraded Bradmer Pharmaceuticals from a “strong-buy” rating to a “moderate buy” rating in a report on Thursday, February 5th.

Bradmer Pharmaceuticals Price Performance